Daily Archive: April 4, 2014

patent 0

Patent Fight on Galvus Soar: Novartis Now Sues Biocon

Swiss giant Novartis has dragged Biocon to Delhi High Court for allegedly infringing patent rights of its diabetes drug “Galvus” and now Biocon cannot manufacture, sell or export vildagliptin until the next hearing. The multinational is seeking an injunction...

Exclusive Webinar Series
Exclusive Webinar Series. Cost: $0 (Free) Limited Seats Available. Don't miss the opportunity, Register Now